The Hemostatic System in Newborns and the Risk of Neonatal Thrombosis

Area of Science:

• Pediatric Hematology
• Neonatal Critical Care
• Thrombosis Research

Background:

• Neonates are highly susceptible to thrombosis, particularly critically ill and premature infants.
• Advancements in neonatal care have increased survival rates, leading to a rise in detected neonatal thrombosis.
• Physiological differences in the hemostatic system of neonates compared to adults contribute to this vulnerability.

Purpose of the Study:

• To summarize the unique hemostatic system characteristics in neonates that predispose them to thrombosis.
• To identify the primary risk factors triggering thrombosis in newborns.
• To outline current therapeutic recommendations for neonatal thrombosis.

Main Methods:

• Review of existing literature on neonatal hemostasis and thrombosis.
• Analysis of physiological differences between neonatal and adult coagulation systems.
• Identification and categorization of neonatal thrombosis risk factors.

Main Results:

• Neonates exhibit distinct coagulation factor levels, turnover rates, and regulatory capacities compared to adults.
• Key risk factors for neonatal thrombosis include central venous catheters, fluid imbalances, liver dysfunction, and sepsis.
• Neonatal hemostasis has a reduced buffer capacity, making it prone to developing thrombosis, with approximately 95% of cases being provoked.

Conclusions:

• The unique hemostatic profile of neonates, coupled with specific risk factors, significantly increases their susceptibility to thrombosis.
• Prompt recognition and management of risk factors are crucial for preventing neonatal thrombosis.
• Low-molecular-weight heparins are established as the primary anticoagulant therapy for neonatal thrombosis.